Background Coronavirus disease 2019 (COVID-19) has been especially dangerous for elderly people. To reduce the risk of transmission from healthcare workers to elderly people, it is of utmost importance to detect possible severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive healthcare workers as early as possible. We aimed to determine whether the Abbott Panbio™ COVID-19 antigen detection rapid diagnostic test (Ag-RDT) could be used as an alternative to reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The second aim was to compare the cycle threshold (Ct) in RT-qPCR with the results of the Ag-RDT. Methods A prospective diagnostic evaluation of the Abbott Panbio™ COVID-19 Ag-RDT among healthcare workers across three elderly care facilities as well as home-based elderly care workers who met clinical criteria for COVID-19 during the second wave of the COVID-19 pandemic. Per healthcare worker, the first nasopharyngeal swab was obtained to perform the Ag-RDT and the second swab for RT-qPCR. A Ct-value of < 40 was interpreted as positive, ≥ 40 as negative. Results A total of 683 healthcare workers with COVID-19 symptoms were sampled for detection of SARS-CoV-2 by both Ag-RDT and RT-qPCR. Sixty-three healthcare workers (9.2%) tested positive for SARS-CoV-2 by RT-qPCR. The overall sensitivity of Ag-RDT was 81.0% sensitivity (95%CI: 69.6–88.8%) and 100% specificity (95%CI: 99.4–100%). Using a cut-off Ct-value of 32, the sensitivity increased to 92.7% (95% CI: 82.7–97.1%). Negative Ag-RDT results were moderately associated with higher Ct-values (r = 0.62) compared to positive Ag-RDT results. Conclusion The Panbio™ COVID-19 Ag-RDT can be used to quickly detect positive SARS-CoV-2 healthcare workers. Negative Ag-RDT should be confirmed by RT-qPCR. In case of severe understaffing and with careful consideration, fully vaccinated healthcare workers with Ag-RDT negative results could work with a mask pending PCR results.
[1]
Gheyath K Nasrallah,et al.
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections
,
2022,
The New England journal of medicine.
[2]
T. Peto,et al.
Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants
,
2022,
The New England Journal of Medicine.
[3]
M. Tollånes,et al.
Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort
,
2021,
Journal of Clinical Virology.
[4]
M. Bonten,et al.
Screening for SARS-CoV-2 infection in asymptomatic individuals using the Panbio COVID-19 Antigen Rapid Test (Abbott) compared to RT-qPCR
,
2020,
medRxiv.
[5]
P. Escribano,et al.
Multicenter evaluation of the Panbio COVID-19 Rapid Antigen-Detection Test for the diagnosis of SARS-CoV-2 infection
,
2020,
medRxiv.
[6]
M. Bonten,et al.
Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection
,
2020,
EClinicalMedicine.
[7]
K. Tsao,et al.
Culture-Based Virus Isolation To Evaluate Potential Infectivity of Clinical Specimens Tested for COVID-19
,
2020,
Journal of Clinical Microbiology.
[8]
World Health Organization.
Contact tracing in the context of COVID-19. Interim guidance
,
2020,
Pediatria i Medycyna Rodzinna.